FFM
MRNA icon

Fullerton Fund Management’s Moderna MRNA Stock Holding History

Fullerton Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-78,060
Closed -$8.32M – 165
2024
Q1 		$8.32M Sell
78,060
-21,990
-22% -$2.22M 0.39% 41
2023
Q4 		$9.95M Buy
100,050
+5,781
+6% +$486K 0.58% 38
2023
Q3 		$9.74M Buy
+94,269
New +$10.5M 0.68% 29
2023
Q1 		– Sell
-4,174
Closed -$750K – 86
2022
Q4 		$750K Sell
4,174
-46,451
-92% -$7.6M 0.06% 60
2022
Q3 		$5.99M Buy
+50,625
New +$7.68M 0.45% 44
2021
Q4 		– Sell
-63,384
Closed -$24.4M – 66
2021
Q3 		$24.4M Buy
+63,384
New +$23.4M 1.48% 21

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fullerton Fund Management's MRNA Position: Q2 2024 in Review

Fullerton Fund Management sold out of Moderna (MRNA) in Q2 2024, closing a stake of 78,060 shares — an estimated $8.32M sold.

Fullerton Fund Management first reported a position in MRNA in Q3 2021 and held it in 6 quarters. The position peaked at $24.4M in Q3 2021. 955 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Fullerton Fund Management reported no remaining Moderna position as of Q2 2024 after selling out during the quarter.
  • Fullerton Fund Management sold 78,060 Moderna shares in Q2 2024, an estimated $8.32M.
  • Fullerton Fund Management first reported a position in Moderna in Q3 2021 and held it in 6 quarters.
  • Fullerton Fund Management's Moderna position peaked at $24.4M in Q3 2021.
  • 955 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Fullerton Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.